Table 13.
Source | Study | Study size (Male:Female) | Cases1 | Controls1 | P values | Overall finding | Units of measure |
---|---|---|---|---|---|---|---|
Glutathione peroxidase | |||||||
Plasma | Yorbik et al. 2002 [71] | 45 cases, (39 M, 6 F) 41 controls, (35 M, 6 F) | 270 ± 40 | 390 ± 80 | < 0.05 | low | U/L |
Söğüt et al. 2003 [72] | 27 cases, (16 M, 11 F) 30 controls, (16 M, 14 F) | 40.9 ± 11.3 | 24.2 ± 6.3 | < 0.0001 | high | U/L | |
Al-Gadani et al. 2009 [81] | 30 cases, (22 M, 8 F) 30 controls, (20 M, 10 F) | 2468.8 ± 999.3 | 1438.5 ± 611.2 | < 0.05 | high | U/L | |
Mostafa et al. 2010 [83] | 44 cases, (30 M,14 F) 44 controls, (30 M, 14 F) | 441.5 (100)2 | 589 (176)2 | < 0.001 | low | U/L | |
Erythrocytes | Golse et al. 1978 [63] | 24 cases, (17 M, 7 F) 6 controls, (2 M, 4 F) |
4.7 ± 0.29 | 8.45 ± 0.95 | < 0.0001 | low | U/g haemoglobin |
Yorbik et al. 2002 [71] | 45 cases, (39 M, 6 F) 41 controls, (35 M, 6 F) | 28.72 ± 2.64 | 38.01 ± 5.03 | < 0.05 | low | U/g haemoglobin | |
Pasca et al. 2006 [74] | 12 cases, (9 M, 3 F) 9 controls, (6 M, 3 F) |
7.75 ± 0.93 | 7.45 ± 0.65 | ns | ns | U/g haemoglobin | |
Vergani et al. 2011 [84] | 28 cases (21 M, 7 F) 32 controls (20 M, 12 F) |
ns | ns | nmols NADPH/min/mg haemoglobin | |||
Platelets | Golse et al. 1978 [63] | 36 cases, (15 M, 21 F) 21 controls, (9 M, 12 F) | 51.53 ± 1.61 | 46.56 ± 2.69 | ns | ns | U/g platelet protein |
Glutathione reductase | |||||||
Plasma | Al-Yafee et al. 2011 [85] | 20 cases (20 M, 0 F) 20 controls (20 M, 0 F) |
70.25 ± 16.35 | 60.19 ± 15.42 | 0.052 | trend high | U/L |
Glutathione-s-transferase | |||||||
Plasma | Al-Yafee et al. 2011 [85] | 20 cases (20 M, 0 F) 20 controls (20 M, 0 F) |
0.42 ± 0.18 | 0.73 ± 0.37 | 0.002 | low | μmol/min/ml |
ns Not significant 1Mean ± standard deviation 2 Median and interquartile range